Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1996 1
1998 1
2003 1
2006 1
2007 3
2008 1
2009 2
2012 2
2013 4
2014 3
2015 8
2016 3
2017 1
2021 2
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial.
Qin S, Chen M, Cheng AL, Kaseb AO, Kudo M, Lee HC, Yopp AC, Zhou J, Wang L, Wen X, Heo J, Tak WY, Nakamura S, Numata K, Uguen T, Hsiehchen D, Cha E, Hack SP, Lian Q, Ma N, Spahn JH, Wang Y, Wu C, Chow PKH; IMbrave050 investigators. Qin S, et al. Lancet. 2023 Nov 18;402(10415):1835-1847. doi: 10.1016/S0140-6736(23)01796-8. Epub 2023 Oct 20. Lancet. 2023. PMID: 37871608 Clinical Trial.
Diagnosis and management of Abernethy syndrome.
Castro Rodríguez J, Rodríguez Perálvarez ML, Montero-Álvarez JL. Castro Rodríguez J, et al. Among authors: montero alvarez jl. Rev Esp Enferm Dig. 2024 Jan;116(1):1-6. doi: 10.17235/reed.2023.9781/2023. Rev Esp Enferm Dig. 2024. PMID: 37522317 Free article.
Endoscopic findings unrelated to portal hypertension in patients with liver cirrhosis undergoing a varicose vein screening programme.
Santos Lucio A, Rodríguez Tirado I, Aparicio Serrano A, Jurado García J, Barrera Baena P, González Galilea Á, Poyato González A, Pleguezuelo Navarro M, Costán Rodero G, Casáis Juanena L, Montero Álvarez JL, de la Mata M, Hervás Molina AJ, Rodríguez-Perálvarez ML. Santos Lucio A, et al. Among authors: montero alvarez jl. Gastroenterol Hepatol. 2022 Jun-Jul;45(6):450-456. doi: 10.1016/j.gastrohep.2021.07.010. Epub 2021 Aug 14. Gastroenterol Hepatol. 2022. PMID: 34400186 English, Spanish.
Efficacy and safety of daclatasvir-based antiviral therapy in hepatitis C virus recurrence after liver transplantation. Role of cirrhosis and genotype 3. A multicenter cohort study.
Salcedo M, Prieto M, Castells L, Pascasio JM, Montero Alvarez JL, Fernández I, Sánchez-Antolín G, González-Diéguez L, García-Gonzalez M, Otero A, Lorente S, Espinosa MD, Testillano M, González A, Castellote J, Casafont F, Londoño MC, Pons JA, Molina Pérez E, Cuervas-Mons V, Pascual S, Herrero JI, Narváez I, Vinaixa C, Llaneras J, Sousa JM, Bañares R. Salcedo M, et al. Among authors: montero alvarez jl. Transpl Int. 2017 Oct;30(10):1041-1050. doi: 10.1111/tri.12999. Epub 2017 Jul 27. Transpl Int. 2017. PMID: 28608619 Free article.
Prevalence and Predictors of Metabolic Syndrome After Liver Transplantation.
Vida Perez L, Montero Alvarez JL, Poyato Gonzalez A, Briceño Delgado J, Costan Rodero G, Fraga Rivas E, Barrera Baena P, De la Mata Garcia M. Vida Perez L, et al. Among authors: montero alvarez jl. Transplant Proc. 2016 Sep;48(7):2519-2524. doi: 10.1016/j.transproceed.2016.08.029. Transplant Proc. 2016. PMID: 27742339
Impact of MELD Allocation System on Waiting List and Early Post-Liver Transplant Mortality.
Jurado-García J, Muñoz García-Borruel M, Rodríguez-Perálvarez ML, Ruíz-Cuesta P, Poyato-González A, Barrera-Baena P, Fraga-Rivas E, Costán-Rodero G, Briceño-Delgado J, Montero-Álvarez JL, de la Mata-García M. Jurado-García J, et al. Among authors: montero alvarez jl. PLoS One. 2016 Jun 14;11(6):e0155822. doi: 10.1371/journal.pone.0155822. eCollection 2016. PLoS One. 2016. PMID: 27299728 Free PMC article.
GCDCA down-regulates gene expression by increasing Sp1 binding to the NOS-3 promoter in an oxidative stress dependent manner.
González-Rubio S, López-Sánchez L, Muñoz-Castañeda J, Linares CI, Aguilar-Melero P, Rodríguez-Perálvarez M, Sánchez-Sánchez R, Fernández-Álvarez A, Casado M, Montero-Álvarez JL, Rodríguez-Ariza A, Muntané J, de la Mata M, Ferrín G. González-Rubio S, et al. Among authors: montero alvarez jl. Biochem Pharmacol. 2015 Jul 1;96(1):39-51. doi: 10.1016/j.bcp.2015.04.017. Epub 2015 Apr 27. Biochem Pharmacol. 2015. PMID: 25931146
Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility.
Ferrín G, Aguilar-Melero P, Rodríguez-Perálvarez M, Montero-Álvarez JL, de la Mata M. Ferrín G, et al. Among authors: montero alvarez jl. Hepat Med. 2015 Apr 13;7:1-10. doi: 10.2147/HMER.S50161. eCollection 2015. Hepat Med. 2015. PMID: 25926760 Free PMC article. Review.
34 results